These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7008171)

  • 1. [When should insulin be resorted to in late diabetes of the adult or in diabetes of the obese?].
    Guillon J; Charbonnel B
    Rev Prat; 1981 Feb; 31(9):639-40, 643-5. PubMed ID: 7008171
    [No Abstract]   [Full Text] [Related]  

  • 2. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
    Shukla UA; Chi EM; Lehr KH
    Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes.
    Gosmanov AR; Umpierrez GE; Karabell AH; Cuervo R; Thomason DB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E8-E15. PubMed ID: 15010337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 6. Two minutes with diabetes: insulin administration.
    Whitehouse FW
    Med Times; 1971 Aug; 99(8):99 passim. PubMed ID: 5566830
    [No Abstract]   [Full Text] [Related]  

  • 7. The place of phenformin in the treatment of diabetes.
    Bloom A
    Postgrad Med J; 1969 May; 45():5-7. PubMed ID: 5364316
    [No Abstract]   [Full Text] [Related]  

  • 8. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus.
    Mito N; Hiyoshi T; Hosoda T; Kitada C; Sato K
    Eur J Clin Nutr; 2002 Apr; 56(4):347-51. PubMed ID: 11965511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early control of diabetic sequelae. Combined insulin treatment also in type 2].
    MMW Fortschr Med; 2000 Jun; 142(25):57. PubMed ID: 10920674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Widened indications. More latitude with insulin analogs].
    MMW Fortschr Med; 2003 Sep; 145(39):52. PubMed ID: 14649078
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diabetes in patients with severe obesity.
    Scheen AJ
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin concentration in non-obese and obese children with type 1 diabetes mellitus.
    Verrotti A; Basciani F; De Simone M; Morgese G; Chiarelli F
    Biomed Pharmacother; 2000 Mar; 54(2):69-73. PubMed ID: 10759289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preservation of insulin sensitivity in obese women without diabetes.
    Ngarmukos C; Chanprasertyothin S; Puavilai G; Ongphiphadhanakul B
    J Med Assoc Thai; 2008 May; 91(5):659-64. PubMed ID: 18672628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin therapy in the type 2 obese diabetic patient. Supplementing the deficit].
    Matthaei S; Häring HU
    MMW Fortschr Med; 2001 May; 143(21):35-7. PubMed ID: 11420829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of drugs in the management of diabetes mellitus.
    Das S
    J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
    Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
    Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.